Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907023 · ClinicalTrials.gov registry record
Transition From Hospital to Home in Solid Organ Transplant (SOT)
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 37
- Enrollment target
NCT00907023: Completed study, sponsored by Medical College of Wisconsin.
NCT00907023 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00907023 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The aim of this study is to determine the influences of discharge teaching and care coordination on how ready a parent is to take their child home from the hospital after a solid organ (kidney, heart and liver) transplant. This study will also look into how the parent handles coping, utilization of healthcare resources, and parent adjustment 3 weeks after discharge from the hospital.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-05 |
What the finished NCT00907023 record still lists
NCT00907023 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00907023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00907023 about?
NCT00907023 is a clinical study titled "Transition From Hospital to Home in Solid Organ Transplant (SOT)". The aim of this study is to determine the influences of discharge teaching and care coordination on how ready a parent is to take their child home from the hospital after a solid organ (kidney, heart and liver) transplant. This study will also look into how the parent handles coping, utilization of ...
What is the current status of trial NCT00907023?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2009-01. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00907023?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia